213 related articles for article (PubMed ID: 31079556)
1. Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors.
Tang T; Abu-Sbeih H; Luo W; Lum P; Qiao W; Bresalier RS; Richards DM; Wang Y
Scand J Gastroenterol; 2019 May; 54(5):538-545. PubMed ID: 31079556
[No Abstract] [Full Text] [Related]
2. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.
de Malet A; Antoni G; Collins M; Soularue E; Marthey L; Vaysse T; Coutzac C; Chaput N; Mateus C; Robert C; Carbonnel F
Eur J Cancer; 2019 Jan; 106():106-114. PubMed ID: 30476730
[TBL] [Abstract][Full Text] [Related]
3. Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
Zhang ML; Neyaz A; Patil D; Chen J; Dougan M; Deshpande V
Histopathology; 2020 Jan; 76(2):233-243. PubMed ID: 31361907
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis.
Panneerselvam K; Amin RN; Wei D; Tan D; Lum PJ; Zhang HC; Richards DM; Altan M; Grivas P; Thompson JA; Thomas AS; Wang Y
J Natl Compr Canc Netw; 2021 Jun; 19(8):896-904. PubMed ID: 34102607
[TBL] [Abstract][Full Text] [Related]
5. Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis.
Abu-Sbeih H; Ali FS; Luo W; Qiao W; Raju GS; Wang Y
J Immunother Cancer; 2018 Sep; 6(1):95. PubMed ID: 30253811
[TBL] [Abstract][Full Text] [Related]
6. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up.
Annunziata ML; Caviglia R; Papparella LG; Cicala M
Dig Dis Sci; 2012 Jun; 57(6):1618-23. PubMed ID: 22350786
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
[TBL] [Abstract][Full Text] [Related]
8. Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors.
Jeay M; Carbonnel F; Robert C; Mussini C; Bellanger C; Meyer A
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102311. PubMed ID: 38430989
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium.
Enestvedt BK; Gralnek IM; Mattek N; Lieberman DA; Eisen G
Gastrointest Endosc; 2008 Mar; 67(3):422-9. PubMed ID: 18206878
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomes.
Yu K; Mathew A; Abraham F; Amin R; Kono M; Overman M; Zhao D; Khan A; Khan MA; Thomas AS; Wang Y
Ann Gastroenterol; 2022; 35(5):514-521. PubMed ID: 36061157
[TBL] [Abstract][Full Text] [Related]
11. Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis.
Ai Q; Chen W; Li Y; Li G
Front Immunol; 2022; 13():840916. PubMed ID: 35720298
[TBL] [Abstract][Full Text] [Related]
12. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
13. Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience.
Parente P; Maiorano BA; Ciardiello D; Cocomazzi F; Carparelli S; Guerra M; Ingravallo G; Cazzato G; Carosi I; Maiello E; Bossa F
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328239
[No Abstract] [Full Text] [Related]
14. Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract.
Nguyen T; Park JY; Scudiere JR; Montgomery E
Am J Surg Pathol; 2009 Sep; 33(9):1355-63. PubMed ID: 19542873
[TBL] [Abstract][Full Text] [Related]
15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
16. Magnetically assisted capsule endoscopy in suspected acute upper GI bleeding versus esophagogastroduodenoscopy in detecting focal lesions.
Ching HL; Hale MF; Sidhu R; Beg S; Ragunath K; McAlindon ME
Gastrointest Endosc; 2019 Sep; 90(3):430-439. PubMed ID: 31082392
[TBL] [Abstract][Full Text] [Related]
17. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
[TBL] [Abstract][Full Text] [Related]
18. Upper Gastrointestinal Involvement in Crohn Disease: Histopathologic and Endoscopic Findings.
Diaz L; Hernandez-Oquet RE; Deshpande AR; Moshiree B
South Med J; 2015 Nov; 108(11):695-700. PubMed ID: 26539952
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
Horjus Talabur Horje CS; Meijer J; Rovers L; van Lochem EG; Groenen MJ; Wahab PJ
Inflamm Bowel Dis; 2016 Aug; 22(8):1896-901. PubMed ID: 27057685
[TBL] [Abstract][Full Text] [Related]
20. Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study.
Bytzer P; Pratt S; Elkin E; Næsdal J; Sörstadius E
Am J Cardiovasc Drugs; 2013 Feb; 13(1):27-35. PubMed ID: 23315343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
